Global Ophthalmology Disorders Drug Market Analysis 2015-2019 and Forecast 2020-2025
Report Code: KNJ204372 No. of Pages: 264 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Snapshot The global Ophthalmology Disorders Drug market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Ophthalmology Disorders Drug by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): Oral Injection External Use Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.): Sanofi Bayer Bausch + Lomb Novartis Usher Syndrome Takeda Pharmaceutical Roche Pfizer Allergan Gilead Sciences Kubota Pharmaceutical Alkeus Pharmaceuticals Astellas Pharma Ferrer Corporate Amgen Inc Editas Medicine Inc ProQR Therapeutics NV ReNeuron Amarantus BioScience Ocugen ReGenX Biosciences Sucampo Pharmaceuticals Orphagen Pharmaceuticals Okuvision Second Sight Medical Acucela Stealth BioTherapeutics Sun Pharma Advanced Research Company AmpliPhi Biosciences Applied Genetic Technologies Asklepios BioPharmaceutical Biovista Spark Therapeutics Caladrius Biosciences Dompe Farmaceutici Dormant Projects Grupo Ferrer Internacional ID Pharma InFlectis BioScience Ionis Pharmaceuticals Ixchel Pharma Khondrion Mimetogen Pharmaceuticals Mitotech M's Science Nanovector SanBio Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.): Juvenile Macular Degeneration (Stargardt Disease) Leber Congenital Amaurosis (LCA) Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Usher Syndrome Retinitis Pigmentosa (Retinitis) Region Coverage (Regional Production, Demand & Forecast by Countries etc.): North America (U.S., Canada, Mexico) Europe (Germany, U.K., France, Italy, Russia, Spain etc.) Asia-Pacific (China, India, Japan, Southeast Asia etc.) South America (Brazil, Argentina etc.) Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents 1 Industry Overview 1.1 Ophthalmology Disorders Drug Industry Figure Ophthalmology Disorders Drug Industry Chain Structure 1.1.1 Overview 1.1.2 Development of Ophthalmology Disorders Drug 1.2 Market Segment 1.2.1 Upstream Table Upstream Segment of Ophthalmology Disorders Drug 1.2.2 Downstream Table Application Segment of Ophthalmology Disorders Drug Table Global Ophthalmology Disorders Drug Market 2015-2025, by Application, in USD Million 1.3 Cost Analysis 2 Industry Environment (PEST Analysis) 2.1 Policy 2.2 Economics 2.3 Sociology 2.4 Technology 3 Ophthalmology Disorders Drug Market by Type 3.1 By Type 3.1.1 Oral Table Major Company List of Oral 3.1.2 Injection Table Major Company List of Injection 3.1.3 External Use Table Major Company List of External Use 3.2 Market Size Table Global Ophthalmology Disorders Drug Market 2015-2019, by Type, in USD Million Figure Global Ophthalmology Disorders Drug Market Growth 2015-2019, by Type, in USD Million Table Global Ophthalmology Disorders Drug Market 2015-2019, by Type, in Volume Figure Global Ophthalmology Disorders Drug Market Growth 2015-2019, by Type, in Volume 3.3 Market Forecast Table Global Ophthalmology Disorders Drug Market Forecast 2020-2025, by Type, in USD Million Table Global Ophthalmology Disorders Drug Market Forecast 2020-2025, by Type, in Volume 4 Major Companies List 4.1 Sanofi (Company Profile, Sales Data etc.) 4.1.1 Sanofi Profile Table Sanofi Overview List 4.1.2 Sanofi Products & Services 4.1.3 Sanofi Business Operation Conditions Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.2 Bayer (Company Profile, Sales Data etc.) 4.2.1 Bayer Profile Table Bayer Overview List 4.2.2 Bayer Products & Services 4.2.3 Bayer Business Operation Conditions Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.3 Bausch + Lomb (Company Profile, Sales Data etc.) 4.3.1 Bausch + Lomb Profile Table Bausch + Lomb Overview List 4.3.2 Bausch + Lomb Products & Services 4.3.3 Bausch + Lomb Business Operation Conditions Table Business Operation of Bausch + Lomb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.4 Novartis (Company Profile, Sales Data etc.) 4.4.1 Novartis Profile Table Novartis Overview List 4.4.2 Novartis Products & Services 4.4.3 Novartis Business Operation Conditions Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.5 Usher Syndrome (Company Profile, Sales Data etc.) 4.5.1 Usher Syndrome Profile Table Usher Syndrome Overview List 4.5.2 Usher Syndrome Products & Services 4.5.3 Usher Syndrome Business Operation Conditions Table Business Operation of Usher Syndrome (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.6 Takeda Pharmaceutical (Company Profile, Sales Data etc.) 4.6.1 Takeda Pharmaceutical Profile Table Takeda Pharmaceutical Overview List 4.6.2 Takeda Pharmaceutical Products & Services 4.6.3 Takeda Pharmaceutical Business Operation Conditions Table Business Operation of Takeda Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.7 Roche (Company Profile, Sales Data etc.) 4.7.1 Roche Profile Table Roche Overview List 4.7.2 Roche Products & Services 4.7.3 Roche Business Operation Conditions Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.8 Pfizer (Company Profile, Sales Data etc.) 4.8.1 Pfizer Profile Table Pfizer Overview List 4.8.2 Pfizer Products & Services 4.8.3 Pfizer Business Operation Conditions Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.9 Allergan (Company Profile, Sales Data etc.) 4.9.1 Allergan Profile Table Allergan Overview List 4.9.2 Allergan Products & Services 4.9.3 Allergan Business Operation Conditions Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.10 Gilead Sciences (Company Profile, Sales Data etc.) 4.10.1 Gilead Sciences Profile Table Gilead Sciences Overview List 4.10.2 Gilead Sciences Products & Services 4.10.3 Gilead Sciences Business Operation Conditions Table Business Operation of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.11 Kubota Pharmaceutical (Company Profile, Sales Data etc.) 4.11.1 Kubota Pharmaceutical Profile Table Kubota Pharmaceutical Overview List 4.11.2 Kubota Pharmaceutical Products & Services 4.11.3 Kubota Pharmaceutical Business Operation Conditions Table Business Operation of Kubota Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 4.12 Alkeus Pharmaceuticals (Company Profile, Sales Data etc.) 4.12.1 Alkeus Pharmaceuticals Profile Table Alkeus Pharmaceuticals Overview List 4.12.2 Alkeus Pharmaceuticals Products & Services 4.12.3 Alkeus Pharmaceuticals Business Operation Conditions Table Business Operation of Alkeus Pharmaceuticals (Sales Revenue, Cost, Gross Margin) 4.13 Astellas Pharma (Company Profile, Sales Data etc.) 4.13.1 Astellas Pharma Profile Table Astellas Pharma Overview List 4.13.2 Astellas Pharma Products & Services 4.13.3 Astellas Pharma Business Operation Conditions Table Business Operation of Astellas Pharma (Sales Revenue, Cost, Gross Margin) 4.14 Ferrer Corporate (Company Profile, Sales Data etc.) 4.14.1 Ferrer Corporate Profile Table Ferrer Corporate Overview List 4.14.2 Ferrer Corporate Products & Services 4.14.3 Ferrer Corporate Business Operation Conditions Table Business Operation of Ferrer Corporate (Sales Revenue, Cost, Gross Margin) 4.15 Amgen Inc (Company Profile, Sales Data etc.) 4.15.1 Amgen Inc Profile Table Amgen Inc Overview List 4.15.2 Amgen Inc Products & Services 4.15.3 Amgen Inc Business Operation Conditions Table Business Operation of Amgen Inc (Sales Revenue, Cost, Gross Margin) 4.16 Editas Medicine Inc (Company Profile, Sales Data etc.) 4.16.1 Editas Medicine Inc Profile Table Editas Medicine Inc Overview List 4.16.2 Editas Medicine Inc Products & Services 4.16.3 Editas Medicine Inc Business Operation Conditions Table Business Operation of Editas Medicine Inc (Sales Revenue, Cost, Gross Margin) 4.17 ProQR Therapeutics NV (Company Profile, Sales Data etc.) 4.17.1 ProQR Therapeutics NV Profile Table ProQR Therapeutics NV Overview List 4.17.2 ProQR Therapeutics NV Products & Services 4.17.3 ProQR Therapeutics NV Business Operation Conditions Table Business Operation of ProQR Therapeutics NV (Sales Revenue, Cost, Gross Margin) 4.18 ReNeuron (Company Profile, Sales Data etc.) 4.18.1 ReNeuron Profile Table ReNeuron Overview List 4.18.2 ReNeuron Products & Services 4.18.3 ReNeuron Business Operation Conditions Table Business Operation of ReNeuron (Sales Revenue, Cost, Gross Margin) 4.19 Amarantus BioScience (Company Profile, Sales Data etc.) 4.19.1 Amarantus BioScience Profile Table Amarantus BioScience Overview List 4.19.2 Amarantus BioScience Products & Services 4.19.3 Amarantus BioScience Business Operation Conditions Table Business Operation of Amarantus BioScience (Sales Revenue, Cost, Gross Margin) 4.20 Ocugen (Company Profile, Sales Data etc.) 4.20.1 Ocugen Profile Table Ocugen Overview List 4.20.2 Ocugen Products & Services 4.20.3 Ocugen Business Operation Conditions Table Business Operation of Ocugen (Sales Revenue, Cost, Gross Margin) 4.21 ReGenX Biosciences (Company Profile, Sales Data etc.) 4.21.1 ReGenX Biosciences Profile Table ReGenX Biosciences Overview List 4.21.2 ReGenX Biosciences Products & Services 4.21.3 ReGenX Biosciences Business Operation Conditions Table Business Operation of ReGenX Biosciences (Sales Revenue, Cost, Gross Margin) 4.22 Sucampo Pharmaceuticals (Company Profile, Sales Data etc.) 4.22.1 Sucampo Pharmaceuticals Profile Table Sucampo Pharmaceuticals Overview List 4.22.2 Sucampo Pharmaceuticals Products & Services 4.22.3 Sucampo Pharmaceuticals Business Operation Conditions Table Business Operation of Sucampo Pharmaceuticals (Sales Revenue, Cost, Gross Margin) 4.23 Orphagen Pharmaceuticals (Company Profile, Sales Data etc.) 4.23.1 Orphagen Pharmaceuticals Profile Table Orphagen Pharmaceuticals Overview List 4.23.2 Orphagen Pharmaceuticals Products & Services 4.23.3 Orphagen Pharmaceuticals Business Operation Conditions Table Business Operation of Orphagen Pharmaceuticals (Sales Revenue, Cost, Gross Margin) 4.24 Okuvision (Company Profile, Sales Data etc.) 4.24.1 Okuvision Profile Table Okuvision Overview List 4.24.2 Okuvision Products & Services 4.24.3 Okuvision Business Operation Conditions Table Business Operation of Okuvision (Sales Revenue, Cost, Gross Margin) 4.25 Second Sight Medical (Company Profile, Sales Data etc.) 4.25.1 Second Sight Medical Profile Table Second Sight Medical Overview List 4.25.2 Second Sight Medical Products & Services 4.25.3 Second Sight Medical Business Operation Conditions Table Business Operation of Second Sight Medical (Sales Revenue, Cost, Gross Margin) 4.26 Acucela (Company Profile, Sales Data etc.) 4.26.1 Acucela Profile Table Acucela Overview List 4.26.2 Acucela Products & Services 4.26.3 Acucela Business Operation Conditions Table Business Operation of Acucela (Sales Revenue, Cost, Gross Margin) 4.27 Stealth BioTherapeutics (Company Profile, Sales Data etc.) 4.27.1 Stealth BioTherapeutics Profile Table Stealth BioTherapeutics Overview List 4.27.2 Stealth BioTherapeutics Products & Services 4.27.3 Stealth BioTherapeutics Business Operation Conditions Table Business Operation of Stealth BioTherapeutics (Sales Revenue, Cost, Gross Margin) 4.28 Sun Pharma Advanced Research Company (Company Profile, Sales Data etc.) 4.28.1 Sun Pharma Advanced Research Company Profile Table Sun Pharma Advanced Research Company Overview List 4.28.2 Sun Pharma Advanced Research Company Products & Services 4.28.3 Sun Pharma Advanced Research Company Business Operation Conditions Table Business Operation of Sun Pharma Advanced Research Company (Sales Revenue, Cost, Gross Margin) 4.29 AmpliPhi Biosciences (Company Profile, Sales Data etc.) 4.29.1 AmpliPhi Biosciences Profile Table AmpliPhi Biosciences Overview List 4.29.2 AmpliPhi Biosciences Products & Services 4.29.3 AmpliPhi Biosciences Business Operation Conditions Table Business Operation of AmpliPhi Biosciences (Sales Revenue, Cost, Gross Margin) 4.30 Applied Genetic Technologies (Company Profile, Sales Data etc.) 4.30.1 Applied Genetic Technologies Profile Table Applied Genetic Technologies Overview List 4.30.2 Applied Genetic Technologies Products & Services 4.30.3 Applied Genetic Technologies Business Operation Conditions Table Business Operation of Applied Genetic Technologies (Sales Revenue, Cost, Gross Margin) 4.31 Asklepios BioPharmaceutical (Company Profile, Sales Data etc.) 4.32 Biovista (Company Profile, Sales Data etc.) 4.33 Spark Therapeutics (Company Profile, Sales Data etc.) 4.34 Caladrius Biosciences (Company Profile, Sales Data etc.) 4.35 Dompe Farmaceutici (Company Profile, Sales Data etc.) 4.36 Dormant Projects (Company Profile, Sales Data etc.) 4.37 Grupo Ferrer Internacional (Company Profile, Sales Data etc.) 4.38 ID Pharma (Company Profile, Sales Data etc.) 4.39 InFlectis BioScience (Company Profile, Sales Data etc.) 4.40 Ionis Pharmaceuticals (Company Profile, Sales Data etc.) 4.41 Ixchel Pharma (Company Profile, Sales Data etc.) 4.42 Khondrion (Company Profile, Sales Data etc.) 4.43 Mimetogen Pharmaceuticals (Company Profile, Sales Data etc.) 4.44 Mitotech (Company Profile, Sales Data etc.) 4.45 M's Science (Company Profile, Sales Data etc.) 4.46 Nanovector (Company Profile, Sales Data etc.) 4.47 SanBio (Company Profile, Sales Data etc.) 5 Market Competition 5.1 Company Competition Table Global Ophthalmology Disorders Drug Sales Revenue 2015-2019, by Company, in USD Million Table Global Ophthalmology Disorders Drug Sales Revenue Share 2015-2019, by Company, in USD Million Figure Global Ophthalmology Disorders Drug Sales Revenue Share in 2019, by Company, in USD Million Table Global Ophthalmology Disorders Drug Sales Volume 2015-2019, by Company, in Volume Table Global Ophthalmology Disorders Drug Sales Volume Share 2015-2019, by Company, in Volume Figure Global Ophthalmology Disorders Drug Sales Volume Share in 2019, by Company, in Volume 5.2 Regional Market by Company Figure North America Ophthalmology Disorders Drug Market Concentration, in 2019 Figure Europe Ophthalmology Disorders Drug Market Market Concentration, in 2019 Figure Asia-Pacific Ophthalmology Disorders Drug MMarket Concentration, in 2019 Figure South America Ophthalmology Disorders Drug Market Concentration, in 2019 Figure Middle East & Africa Ophthalmology Disorders Drug Market Concentration, in 2019 6 Demand by End Market 6.1 Demand Situation 6.1.1 Demand in Juvenile Macular Degeneration (Stargardt Disease) Figure Ophthalmology Disorders Drug Demand in Juvenile Macular Degeneration (Stargardt Disease), 2015-2019, in USD Million Figure Ophthalmology Disorders Drug Demand in Juvenile Macular Degeneration (Stargardt Disease), 2015-2019, in Volume 6.1.2 Demand in Leber Congenital Amaurosis (LCA) Figure Ophthalmology Disorders Drug Demand in Leber Congenital Amaurosis (LCA), 2015-2019, in USD Million Figure Ophthalmology Disorders Drug Demand in Leber Congenital Amaurosis (LCA), 2015-2019, in Volume 6.1.3 Demand in Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Figure Ophthalmology Disorders Drug Demand in Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), 2015-2019, in USD Million Figure Ophthalmology Disorders Drug Demand in Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), 2015-2019, in Volume 6.1.4 Demand in Usher Syndrome Figure Ophthalmology Disorders Drug Demand in Usher Syndrome, 2015-2019, in USD Million Figure Ophthalmology Disorders Drug Demand in Usher Syndrome, 2015-2019, in Volume 6.1.5 Demand in Retinitis Pigmentosa (Retinitis) Figure Ophthalmology Disorders Drug Demand in Retinitis Pigmentosa (Retinitis), 2015-2019, in USD Million Figure Ophthalmology Disorders Drug Demand in Retinitis Pigmentosa (Retinitis), 2015-2019, in Volume 6.2 Regional Demand Comparison Table Regional Demand Comparison List Table Major Application in Different Regions 6.3 Demand Forecast Table Ophthalmology Disorders Drug Demand Forecast 2020-2025, by Application, in USD Million Figure Ophthalmology Disorders Drug Market Growth 2020-2025, by Application, in USD Million Figure Ophthalmology Disorders Drug Market Share in 2025, by Application, in USD Million Table Ophthalmology Disorders Drug Demand Forecast 2020-2025, by Application, in Volume Table Ophthalmology Disorders Drug Market Growth 2020-2025, by Application, in Volume Table Ophthalmology Disorders Drug Market Share in 2025, by Application, in Volume 7 Region Operation 7.1 Regional Production Table Ophthalmology Disorders Drug Production 2015-2019, by Region, in USD Million Table Ophthalmology Disorders Drug Production 2015-2019, by Region, in Volume 7.2 Regional Market Table Global Ophthalmology Disorders Drug Market 2015-2019, by Region, in USD Million Table Global Ophthalmology Disorders Drug Market Share 2015-2019, by Region, in USD Million Table Global Ophthalmology Disorders Drug Market 2015-2019, by Region, in Volume Table Global Ophthalmology Disorders Drug Market Share 2015-2019, by Region, in Volume 7.3 by Region 7.3.1 North America 7.3.1.1 Overview Figure North America Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in USD Million Figure North America Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in Volume 7.3.1.2 by Country (U.S., Canada, Mexico) Table North America Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in USD Million Table North America Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in Volume 7.3.2 Europe 7.3.2.1 Overview Figure Europe Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in USD Million Figure Europe Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in Volume 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.) Table Europe Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in USD Million Table Europe Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in Volume 7.3.3 Asia-Pacific 7.3.3.1 Overview Figure Asia-Pacific Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in USD Million Figure Asia-Pacific Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in Volume 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.) Table Asia-Pacific Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in USD Million Table Asia-Pacific Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in Volume 7.3.4 South America 7.3.4.1 Overview Figure South America Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in USD Million Figure South America Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in Volume 7.3.4.2 by Country (Brazil, Argentina etc.) Table South America Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in USD Million Table South America Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in Volume 7.3.5 Middle East & Africa 7.3.5.1 Overview Figure Middle East & Africa Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in USD Million Figure Middle East & Africa Ophthalmology Disorders Drug Market Size and Growth 2015-2019, in Volume 7.3.5.2 by Country (Saudi Arabia, South Africa etc.) Table Middle East & Africa Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in USD Million Table Middle East & Africa Ophthalmology Disorders Drug Market Size 2015-2019, by Country, in Volume 7.4 Regional Import & Export 7.5 Regional Forecast Table Ophthalmology Disorders Drug Market Forecast 2020-2025, by Region, in USD Million Table Ophthalmology Disorders Drug Market Forecast 2020-2025, by Region, in Volume 8 Marketing & Price 8.1 Price and Margin 8.1.1 Price Trends 8.1.2 Factors of Price Change Table Price Factors List 8.1.3 Manufacturers Gross Margin Analysis 8.2 Marketing Channel Figure Marketing Channels Overview 9 Research Conclusion
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : info@kandjmarketresearch.com